ANI Pharmaceuticals (ANIP) has drawn some attention lately as its stock navigates market shifts. This has prompted investors to take a closer look at its recent performance and what could be driving ...

And I do have several favorite stocks that fit that description. My top growth stock to buy in November is one that I've ...

I know how destructive unchecked addiction can be. All the victims of the ongoing opioid crisis do, too. And this is about more than addiction — as when rare but real cases of myocarditis appeared in ...

Coming up: earnings from AMD, Palantir, top pharmaceutical and tech firms; private-sector employment report; consumer sentiment.

AptarGroup stock faces a 25% drop and growth headwinds, but valuation is improving. Learn if ATR offers a compelling ...

The departure came the same day that a drugmaker connected to one of Dr. George Tidmarsh’s former business associates filed a ...

Square Pharmaceuticals, the country's leading drug manufacturer, reported a 15% rise in consolidated net profit to Tk2,397 crore for FY25, driven by strong performances from its subsidiaries and ...

Novo Nordisk attempts to acquire weight-loss drug company Metsera during government shutdown, potentially avoiding FTC ...

Learn about the massive recall of atorvastatin, the most prescribed cholesterol-lowering drug in the US, and find out what you need to do if you are affected.

George Tidmarsh, who resigned Sunday, is accused in a lawsuit of seeking a bribe and defaming a drug.

Otsuka Pharma enters licensing agreement with 4D Molecular Therapeutics for ophthalmic gene therapy drug candidate, 4D-150: Tokyo Monday, November 3, 2025, 11:00 Hrs [IST] Otsuka ...